telehealth glp-1 crackdown news The FDA announced plans to take action against non-FDA-approved receptor agonists, a move that prompted company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the FDA Issues 30 Warning Letters

Senegenin showed a doseresponse regulatory effect after the intervention

But overall, participants on GLP-1 drugs experienced fewer sight-threatening complications related to their diabetic retinopathy and required less invasive eye treatments compared to the group taking other diabetes medications

She now coaches women, who find her via social media, on their own microdosing journeys

Discovery of bacteroides uniformis F18-22 as a safe and novel probiotic bacterium for the treatment of ulcerative colitis from the healthy human colon

Pharmacological Reports , 2018 Injectable BPC-157 Best for : Severe IBD, post-surgical gut recovery, or systemic inflammation Dose : 250500mcg per day (subcutaneous, not near injury site) How to inject : Use an insulin syringe for SubQ injection in the abdominal area Cycle length : 24 weeks, with reassessment While injections are more bioavailable, many users report effective gut symptom relief using oral capsulesespecially when taken consistently